Effect of Guduchyadi Kwath in the Management of Ekakustha (Psoriasis)
Phase 2
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2022/06/043098
- Lead Sponsor
- ational institute of ayurveda Jaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age- Between 18- 59 years
2. Sex- Male & Female patients.
3. Patient willing to participate in clinical trial.
4. Patient having clinical signs & symptoms of
Ekakustha w.s.r. to Psoriasis.
5. Patients having chronicity less than five years duration
Exclusion Criteria
1.Age- below 18years and above 59 years.
2. Patient with long term history of steroid and cytotoxic treatment.
3. Patients having concomitant illness like uncontrolled hypertension, diabetes mellitus, HIV, malignancy etc.
4. Patients having other associated skin disease like eczema, secondary bacterial infection.
5. Patient participated in any clinical trial within last 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in Psoriasis Area and Severity Index (PASI) ScoreTimepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method 1.Asvedana (loss of perspiration) <br/ ><br>2.MahÄ?vÄ?stu / Maá¹?á¸?ala (lisions distibution) <br/ ><br>3.MatsyaÅ?akalopama (Scaling) <br/ ><br>4.Ká¹?á¹£á¹?a arÅ«á¹?a vará¹?a / Abhrakpatrasama (Discoloration) <br/ ><br>5.Kaá¹?dÅ« (Itching) <br/ ><br>6.Ruká¹£atÄ? (Dryness) <br/ ><br>changes in above parameters.Timepoint: 3 weeks